Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19920054 | 0.89 | TRPM8 (0.37) | SMN1; SMN2KDM4ETRPM8NPC1RAB9A | |
| SCHEMBL18105689 | 0.87 | TRPM8 (0.49) | ALDH1A1KDM4ETRPM8NPC1RAB9A | |
| SCHEMBL18105748 | 0.84 | CYP2C19 (0.55) | SMN1; SMN2ALDH1A1CYP2C19TRPM8NPC1 | |
| SCHEMBL18105910 | 0.84 | SMN1; SMN2 (0.48) | SMN1; SMN2ALDH1A1KDM4ECYP2C19NPC1 | |
| SCHEMBL18105747 | 0.83 | ALDH1A1 (0.52) | SMN1; SMN2ALDH1A1CYP2C19NPC1RAB9A | |
| SCHEMBL4889806 | 0.82 | TRPM8 (0.57) | SMN1; SMN2ALDH1A1KDM4ETRPM8HPGD | |
| SCHEMBL18105779 | 0.81 | KDM4E (0.55) | SMN1; SMN2ALDH1A1KDM4ECYP2C19HSD17B10 | |
| SCHEMBL18105713 | 0.79 | TRPM8 (0.49) | SMN1; SMN2ALDH1A1TRPM8MAPTMEN1 | |
| SCHEMBL18105704 | 0.78 | GAA (0.53) | ALDH1A1TRPM8NPC1RAB9AMEN1 | |
| SCHEMBL18105700 | 0.76 | TRPM8 (0.47) | SMN1; SMN2ALDH1A1KDM4ECYP2C19TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10494330-B2 | Methyl menthol derivative and cooling agent composition containing same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-12-03 | — | — | US | disclosed |
| EP-3275962-B1 | METHYL MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION CONTAINING SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2019-10-02 | — | — | EP | disclosed |
| US-20180057447-A1 | METHYL MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION CONTAINING SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-03-01 | — | — | US | disclosed |
| EP-3275962-A1 | METHYL MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION CONTAINING SAME | Takasago International Corporation (JP) | 2018-01-31 | — | — | EP | disclosed |
| WO-2016153011-A1 | METHYL MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION CONTAINING SAME | 高砂香料工業株式会社 | 2016-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057447-A1 | METHYL MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION CONTAINING SAME | TRPM4, TAS2R41, TRPM2 | SMN1; SMN2 1030/4885ALDH1A1 902/4885KDM4E 590/4885 |
| US-10494330-B2 | Methyl menthol derivative and cooling agent composition containing same | TRPM4, TAS2R41, TRPM2 | SMN1; SMN2 1030/4885ALDH1A1 902/4885KDM4E 590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.